Market Overview

Premature Ejaculation Therapeutics | A Pipeline Analysis Report 2018 | Technavio

Share:

Technavio has announced their latest pipeline analysis report on the premature
ejaculation therapeutics market
. The report includes a detailed
analysis of the pipeline molecules under investigation within the
defined data collection period to treat premature ejaculation
therapeutics.

This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20180723005584/en/

Technavio has published a new report on the drug development pipeline for premature ejaculation, inc ...

Technavio has published a new report on the drug development pipeline for premature ejaculation, including a detailed study of the pipeline molecules. (Graphic: Business Wire)

This report by Technavio
presents a detailed analysis of the market, including regulatory
framework, drug development strategies, recruitment strategies, and key
companies that are expected to play an essential role in the growth of
the market in the future.

This report is available at a USD 1,000 discount for a limited time
only:
View
market snapshot before purchasing

Premature ejaculation therapeutics: Market
overview

Premature ejaculation is a form of sexual dysfunction in which a man
ejaculates sooner than expected by the partner during sexual
intercourse. Premature ejaculation is caused due to both psychological
and medical factors, including stress and diabetes. The premature
ejaculation therapeutics report classifies the syndrome in two types
such as primary and secondary. Primary premature ejaculation occurs from
the time a male becomes sexually active. Secondary premature
ejaculation, also known as acquired premature ejaculation, develops
after a man has had previous sexual experiences without ejaculatory
problems.

According to a senior market research analyst at Technavio, "Therapeutic
drugs, exercises, and home remedies are precise treatments for premature
ejaculation. Owing to the rising incidences and awareness of the
syndrome, the need for the drug development for premature ejaculation
therapeutics has increased considerably in the recent years."

Premature ejaculation therapeutics:
Segmentation analysis

This pipeline analysis report segments the premature ejaculation
therapeutics market based on therapies employed (monotherapy and
combination therapy), RoA (oral, and parenteral), therapeutic modality
(small molecule, and protein), targets (acetylcholine vesicle, and
oxytocin receptor), MoA (acetylcholine release inhibitor, and oxytocin
receptor antagonist), geographical segmentation (US, and UK) and
recruitment status (active, not recruiting, and terminated). It provides
an in-depth analysis of the prominent factors influencing the market,
including drivers, opportunities, trends, and industry-specific
challenges.

Based on therapeutic modality, more than 57% of the molecules that are
being investigated for the treatment of premature ejaculation are small
molecule.

Looking for more information on this market? Request
a free sample report

Technavio's sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Scope of the Report

Regulatory Framework

Drug Development Landscape

  • Drugs under development
  • Indications coverage

Drug Development Strategies

  • Therapies employed
  • RoA
  • Therapeutic modality
  • Geographical coverage

Recruitment Strategies

  • Recruitment status
  • Gender
  • Age

Key Companies

  • Type of players
  • Company overview

Discontinued or Dormant Molecules

About Technavio

Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio's comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team
at media@technavio.com.

View Comments and Join the Discussion!